Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Population implications of electrocardiographic left ventricular hypertrophy.Am J Cardiol. 1987; 60: 85I-93I
- Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham Study.Ann Intern Med. 1970; 72: 813-822
- Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study.N Engl J Med. 1990; 322: 1561-1566
- Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.Lancet. 2002; 359: 995-1003
- Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond.Stat Med. 2008; 27: 157-172
- Net reclassification indices for evaluating risk prediction instruments: a critical review.Epidemiology. 2014 Jan; 25: 114-121
- Echocardiographic measurements in normal subjects from infancy to old age.Circulation. 1980; 62: 1054-1061
- The Cardiovascular Health Study: design and rationale.Ann Epidemiol. 1991; 1: 263-276
- Incident heart failure prediction in the elderly: the Health ABC heart failure score.Circ Heart Fail. 2008; 1: 125-133
- Classification of the electrocardiogram for population studies: Minnesota Code.J Electrocardiol. 1969; 2: 305-310
- Race- and sex-specific ECG models for left ventricular mass in older populations. Factors influencing overestimation of left ventricular hypertrophy prevalence by ECG criteria in African-Americans.J Electrocardiol. 2000; 33: 205-218
- Sex, age, and disease affect echocardiographic left ventricular mass and systolic function in the free-living elderly. The Cardiovascular Health Study.Circulation. 1995; 91: 1739-1748
- Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.Am J Cardiol. 1986; 57: 450-458
- Body size adjustments for left ventricular mass by cardiovascular magnetic resonance and their impact on left ventricular hypertrophy classification.Int J Cardiovasc Imaging. 2010; 26: 459-468
- General cardiovascular risk profile for use in primary care: the Framingham Heart Study.Circulation. 2008; 117: 743-753
- Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study.Ann Epidemiol. 1995; 5: 278-285
- Regression modelling strategies for improved prognostic prediction.Stat Med. 1984; 3: 143-152
- A randomized trial of intensive versus standard blood-pressure control.N Engl J Med. 2015; 373: 2103-2106
- Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals.JAMA. 2012; 308: 788-795
- Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy.Circulation. 1990; 81: 815-820
- M-mode echocardiographic predictors of six- to seven-year incidence of coronary heart disease, stroke, congestive heart failure, and mortality in an elderly cohort (the Cardiovascular Health Study).Am J Cardiol. 2001; 87: 1051-1057
This research was supported by contracts HHSN268201200036 C, HHSN268200800007 C, N01 HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01HC85086, and grant HL080295 from the National Heart, Lung, and Blood Institute (NHLBI), Bethesda, Maryland, with additional contribution from the National Institute of Neurological Disorders and Stroke (NINDS), Bethesda, Maryland. Additional support was provided by AG023629 from the National Institute on Aging (NIA), Bethesda, Maryland. A full list of principal CHS investigators and institutions can be found at http://www.chs-nhlbi.org/PI.htm. Dr. Desai was supported by grant T32 HL-69771-8 from the National Institutes of Health, Bethesda, Maryland.
See page 689 for disclosure information.